Fingerprint
Dive into the research topics where Su Jin Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)
Kim, M., Kim, Y. J., Suh, K. J., Kim, S. H., Kim, J. E., Jeong, J., Hong, J. Y., Lee, J., Lee, S. J., Oh, S. Y., Kim, J. H., Lee, G. W., Ahn, M. S., Choi, W., Choi, Y. J., Lee, T., Oum, C., Kim, J., Kim, Y. S. & Ahn, J. H., 1 Jan 2025, In: Cancer. 131, 1, e35609.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Imatinib in c‑KIT‑mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18‑05 Trial)
Kim, H. R., Lee, S. J., Ahn, M. S., Kim, J. E., Kang, M. J., Hong, J. Y., Lee, J. & Kim, S. T., 2024, In: Journal of Cancer Research and Therapeutics. 20, 3, p. 972-978 7 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)
Kim, K. H., Jung, M., Lee, H. J., Lee, S. J., Kim, M., Ahn, M. S., Choi, M. Y., Lee, N. R. & Shin, S. J., Nov 2023, In: European Journal of Cancer. 193, 113312.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)
Kim, K. H., Lee, H. J., Lee, S. J., Kim, M., Ahn, M. S., Choi, M. Y., Lee, N. R., Jung, M. & Shin, S. J., Oct 2022, In: European Journal of Cancer. 174, p. S85-S86Research output: Contribution to journal › Article › peer-review
Open Access -
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
Kim, H. R., Lee, S. J., Park, S., Jung, H. A., Lee, S. H., Jeong, H. S., Chung, M. K. & Ahn, M. J., Jul 2022, In: Cancer Research and Treatment. 54, 3, p. 719-727 9 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations